Medifocus raises $3.5 million through a convertible debt financing round, part of the company's private stock offering.
Medifocus (PINK:MDFZF) said it brought in $3.5 million in a private offering of convertible debt, a raise tied to company's August non-brokered private placement of $6 million.
Second Sight Medical registers for a $10 million funding round to back its Argus II 'bionic eye' retinal implant.
Second Sight Medical is hoping to raise $10.5 million, according to a regulatory filing, as it brings its "bionic eye" Argus II retinal implant to the U.S. market.
The device, comprised of an eyeglass-mounted camera and an electrical stimulator implanted in the eye, works by converting video images captured by a miniature camera housed in the patient's glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes on the surface of the retina.
Boston Scientific sells the Prolieve benign prostatic hyperplasia treatment system back to Medifocus in a deal worth up to $5 million.
Updated June 28, 2012, at 12:45 p.m. with comments from Medifocus.
Medical device titan Boston Scientific (NYSE:BSX) sold the Prolieve business back to Medifocus (PINK:MDFZF) in a deal valued at $5 million.
European Union regulators are ready to OK Johnson & Johnson's $21.3 billion buyout of Synthes; also, Study: Patent-sharing the rising tide that lifts all boats; Standard & Poor's boosts CareFusion rating; Delcath inks Spanish training deal; Kozlowski is back in New York; DoD exercises option on $71M Zimmer contract; PE firm prepping for Medidata takeover?; C-level shifts at Alphatec prompt NASDAQ warning; PositiveID taps investor relations shop Trilogy Capital; plus, a Funding Roundup and analysts' ups and downs.
European Union regulators are poised to give the OK to Johnson & Johnson's (NYSE:JNJ) $21.3 billion acquisition of Swiss orthopedic giant Synthes, according to Reuters.
, CareFusion Corp.
, Delcath Systems Inc.
, Elliott Management
, Emergent Medical
, InVivo Therapeutics Corp.
, Johnson & Johnson
, Medidata Solutions
, PositiveID Corp.
, SpectraScience Inc.
, Standard & Poor's
, Stealth Therapeutics
, Synthes Inc.
, Tepha Inc.
, Trilogy Capital
, Tyco Healthcare
, U.S. Defense Dept.
, Vista Capital Partners
, Young Innovations
, Alphatec Spine Inc.